Merus Announces Financial Results for the Second Quarter 2018 & Mid-year Operating Results

World News: . []

UTRECHT The Netherlands Aug 10 2018 GLOBE NEWSWIRE -- Merus NV NasdaqMRUS Merus we our or the “Company”), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonic s®)...

More news and information about Merus N.V.

Published By:

Globe Newswire: 13:35 GMT Friday 10th August 2018

Published: .

Search for other references to "merus" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us